The IHCV team provides expertise in a broad range of fields, including the medical, business and legal fields. An advisory panel of medical and business leaders from a wide range of health related disciplines provides support to the management team. This has created a highly effective platform for generating deal flow, assessing the scientific, commercial and investment viability of potential transactions, as well as executing transactions, creating value in portfolio companies, and facilitating exits.
The management team in Israel consists of five people:
 |
Dr. Hadar Ron, Managing Partner: Dr. Ron is a physician and attorney. She has extensive medical, legal and management experience in insurance companies, law firms, medical and educational institutions. Her legal and management expertise includes venture capital consulting, medical malpractice, general and medical insurance and legal practice.
Hadar holds an MD from the Sackler School of Medicine, Tel Aviv University, and an LL.B. in Law from Tel Aviv University. |
 |
Avner Lushi, Managing Director: Prior to joining IHCV in 2004, Avner was a Partner and CEO of Life Sciences Transaction Support Ltd. (LTS). LTS is a PriceWaterhouseCoopers subsidiary which provides investment banking and business development services to Israeli and Israeli-related life science companies.
Avner is an attorney by profession. He holds an L.L.M. from the Hebrew University of Jerusalem (Magna Cum Laude), an L.L.B. in Law and a B.A. in Economics from Haifa University (Magna Cum Laude). |
 |
Eran Perry, Managing Director: Prior to joining IHCV in 2006, Eran worked at McKinsey & Company where he served some of the leading players in the pharmaceutical industry. Prior to that Eran worked for Novartis in its Global Oncology Business Unit.
Eran is an attorney by profession. He holds an M.B.A. from Columbia University, a L.L.B. in Law and B.Sc. in Mathematics and Computer Science from Tel Aviv University. |
 |
Dr. Alona Weiss, Senior Analyst: Prior to joining IHCV in 2005, Alona served as a Senior Licensing Officer at Yeda Research and Development Ltd. – the technology transfer arm of the Weizmann Institute of Science. Prior to that she was a Research Fellow at Harvard Medical School and at Massachusetts General Hospital. She has also held several consulting positions at life science companies in the Boston area.
Alona holds a Ph.D. in Molecular Biology and Biochemistry from the Hebrew University of Jerusalem, a M.Sc. in Life Sciences from the Weizmann Institute of Science, and a B.Sc. from the Hebrew University of Jerusalem (Magna Cum Laude). |
 |
Daniella Horev, Administrative Manager: Daniella served in several senior administrative positions. Prior to joining IHCV in 2001, Daniella served as an Administrative Manager at TelesensKSCL Israel, a subsidiary of a public German software company. Prior to that she acted as a marketing & sales manager for Medogar Ltd., an Israeli firm focused on importing and distributing pharmaceuticals & medical equipment.
Daniella holds a BA degree from Tel Aviv University. |